Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug development inputs & services earnings season. Companies specializing in drug ...
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...